Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Psoriasis, Moderate to Severe”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT00400725
What this trial is testing

Maintenance Effect of Clobex Shampoo on Participants With Moderate to Severe Scalp Psoriasis

Who this might be right for
Scalp Psoriasis
Galderma R&D 288
Large-scale testing (Phase 3)Active Not RecruitingNCT06640517
What this trial is testing

Study of the Efficacy, Safety, Pharmacokinetics, and Immunogenicity of Netakimab in Children With Moderate to Severe Plaque Psoriasis

Who this might be right for
Plaque Psoriasis
Biocad 140
Not applicableStudy completedNCT04541810
What this trial is testing

Oral Upadacitinib (RINVOQ) Tablets to Assess Adverse Events and Change in Disease Symptoms in Korean Participants With Moderate to Severe Active Rheumatoid Arthritis, Atopic Dermatitis, Ankylosing Spondylitis or Psoriatic Arthritis

Who this might be right for
Rheumatoid Arthritis (RA)Atopic Dermatitis (AD)Ankylosing Spondylitis (AS)+1 more
AbbVie 2,369
Post-approval studies (Phase 4)Study completedNCT00967538
What this trial is testing

Safety and Efficacy of Etanercept in Patients With Psoriasis Who Failed to Respond to Other Biologic Treatments

Who this might be right for
Psoriasis
Innovaderm Research Inc. 89
Post-approval studies (Phase 4)Study completedNCT06032858
What this trial is testing

Efficacy and Safety of Apremilast in Psoriasis

Who this might be right for
Psoriasis
Ghurki Trust and Teaching Hospital 30
Not applicableStudy completedNCT01555606
What this trial is testing

An Observational Study to Evaluate Patient-Reported Experiences of Living With Moderate-to-Severe Plaque Psoriasis

Who this might be right for
Moderate to Severe Plaque Psoriasis
Janssen Biotech, Inc. 108
Post-approval studies (Phase 4)UnknownNCT01939132
What this trial is testing

Protocol for H.P. Acthar Gel in Moderately to Severely Active Psoriatic Arthritis

Who this might be right for
Psoriatic Arthritis
Fiechtner, Justus J., M.D., P.C. 10
Large-scale testing (Phase 3)Study completedNCT02694523
What this trial is testing

BI 655066/ABBV-066 (Risankizumab) Compared to Active Comparator (Adalimumab) in Patients With Moderate to Severe Chronic Plaque Psoriasis

Who this might be right for
Psoriasis
AbbVie 684
Large-scale testing (Phase 3)Study completedNCT00570986
What this trial is testing

A Study Comparing the Safety and Efficacy of Two Dosing Regimens of ABT-874 to Placebo in Subjects With Moderate to Severe Chronic Plaque Psoriasis

Who this might be right for
Plaque Psoriasis
AbbVie (prior sponsor, Abbott) 1,465
Large-scale testing (Phase 3)Study completedNCT01646073
What this trial is testing

Safety and Efficacy Study of Adalimumab in the Treatment of Plaque Psoriasis

Who this might be right for
Plaque Psoriasis
AbbVie (prior sponsor, Abbott) 425
Large-scale testing (Phase 3)Study completedNCT03668613
What this trial is testing

Study to Assess the Long-term Safety, Tolerability, Efficacy of Secukinumab in Pediatric Patients of Age 6 to <18 Years, With Moderate to Severe Plaque Psoriasis

Who this might be right for
Moderate to Severe Chronic Plaque-type Psoriasis
Novartis Pharmaceuticals 84
Testing effectiveness (Phase 2)WithdrawnNCT01006096
What this trial is testing

Erlotinib for Treatment of Psoriasis

Who this might be right for
Psoriasis
Northwestern University
Large-scale testing (Phase 3)UnknownNCT02701205
What this trial is testing

Safety and Efficacy Study of Etanercept (Qiangke®) to Treat Moderate to Severe Plaque Psoriasis

Who this might be right for
Plaque PsoriasisPsoriasis
Shanghai Celgen Bio-Pharmaceutical Co.,Ltd 216
Large-scale testing (Phase 3)Study completedNCT03518047
What this trial is testing

Risankizumab Therapy Versus Placebo for Subjects With Psoriasis in the Russian Federation

Who this might be right for
Psoriasis
AbbVie 50
Post-approval studies (Phase 4)Study completedNCT00512187
What this trial is testing

Moderate Weight Loss Makes Obese Patients With Severe Chronic Plaque Psoriasis Responsive to Sub-Optimal Dose of Cyclosporine: an Investigator Blinded, Controlled, Randomized Clinical Trial

Who this might be right for
Chronic Plaque PsoriasisObesity
Universita di Verona
Testing effectiveness (Phase 2)Looking for participantsNCT06912165
What this trial is testing

WD-890 in Participants With Moderate-to-Severe Plaque Psoriasis

Who this might be right for
Brief Description of Focus of Study
Zhejiang Wenda Pharma Technology LTD. 140
Testing effectiveness (Phase 2)Study completedNCT00143806
What this trial is testing

Transitioning From Cyclosporine to Alefacept in Psoriasis

Who this might be right for
Psoriasis
University of Medicine and Dentistry of New Jersey 13
Not applicableEnded earlyNCT01156532
What this trial is testing

Clinical Effectiveness and Impact on Health-related Quality of Life in Peruvian Patients With Psoriasis After 16 Weeks of Adalimumab Therapy

Who this might be right for
Moderate to Severe Psoriasis
AbbVie (prior sponsor, Abbott) 30
Post-approval studies (Phase 4)Study completedNCT05510063
What this trial is testing

Pharmacokinetics, Efficacy, Safety, and Immunogenicity of SB5 Versus Humira in Subjects With Moderate to Severe Chronic Plaque Psoriasis

Who this might be right for
Plaque Psoriasis
Samsung Bioepis Co., Ltd. 371
Testing effectiveness (Phase 2)Study completedNCT05268016
What this trial is testing

Efficacy and Safety of ME3183 in Subjects With Moderate to Severe Plaque Psoriasis

Who this might be right for
Plaque Psoriasis
Meiji Pharma USA Inc. 132
Next Page